Stable RNA-DNA hybrids formed by invasion of an RNA strand into duplex DNA, termed R-loops, are notorious for provoking genome instability especially when they arise during transcription. However, in some instances (DNA replication and class switch recombination), R-loops are useful so long as their existence is carefully managed to avoid them persisting. A recent flow of research papers establishes a newly discovered use for R-loops as key intermediates in a prokaryotic immune system called CRISPR (Clustered Regularly Interspersed Short Palindromic Repeats). Structures and mechanism of ribonucleoprotein complexes ("Cascades") that form CRISPR R-loops highlight precision targeting of duplex DNA that has sequence characteristics marking it as foe, enabling nucleolytic destruction of DNA and recycling the Cascade. We review these significant recent breakthroughs in understanding targeting/interference stages of CRISPR immunity and discuss questions arising, including a possible link between targeting and adaptive immunity in prokaryotes.
RNA-DNA Hybrids and R-Loops
Double-helical structures of B-form DNA and Aform RNA were reported in the 1950s, [1] [2] [3] [4] but to satisfy the central "dogma" of molecular biology ("DNA makes RNA makes protein"), it was apparent that RNA-DNA hybrids might need to form. This was shown to be possible in 1960, 5 and their atomic structures show stable duplex that is closer in dimensions to A-form helix. 6 Physiological relevance of natural RNA-DNA hybrids has been described in several contexts, summarised in Table 1 . Most familiar are hybrids formed during transcription and DNA replication. Atomic resolution structures of RNA polymerase transcription complexes show short (12-20 bp) RNA-DNA hybrids. [17] [18] [19] The hybrids are transient as structural features of RNA polymerases and proximity of RNA binding proteins (e.g., for translation) steward nascent RNA away from template DNA. 20, 21 Transient RNA-DNA hybrids are also characteristic of DNA replication, as Okazaki fragments at replication fork lagging strands 22, 23 and in tRNA primed DNA synthesis by a reverse transcriptase first reported in 1970. 24, 25 RNA-DNA hybrids are sometimes stabilised as Rloops, defined as an RNA strand invaded into duplex DNA, base pairing with one DNA strand and displacing the other as a single-stranded DNA (ssDNA) loop (Fig. 1) . The name R-loop is used because of the resemblance of these molecules to strand invasion intermediates of homologous recombination called D-loops, which are composed solely of DNA. R-loops themselves are implicated in a specialised type of recombination, site-specific class switch recombination (CSR) in vertebrate immune systems. 15 Guanine-rich DNA sequences are important for initiating R-loop formation in CSR, and DNA negative supercoiling is another key context that promotes R-loop formation. 7, 26 R-loops were first identified at bacterial ColE1 plasmid origins of replication, 27 and similar mechanisms prime replication in mitochondria 10 and viruses.
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R-loops were also seen in in vitro transcription reactions 28 that led to many more studies establishing the importance of RNaseH in removing R-loops after initiation of replication and of DNA topoisomerase I preventing R-loop formation during transcription, summarised in Table 2 . The importance of R-loop management in cells is made clear by studies showing mutagenic effects of persistent R-loops through conflict with DNA replication and provoking of illegitimate homologous recombination, reviewed recently. 8 Here, we focus on a protein-RNA complex that forms R-loops by a precise targeting mechanism guided to duplex DNA. The mechanism is a part of CRISPR/Cas immunity, a newly discovered system in bacteria and archaea that can seek and destroy invasive nucleic acids from virus or plasmid. Emergence of CRISPR/Cas has been striking, not least because its mechanisms are underpinned by adaptive immunity that is expressed in RNA sequences. We highlight some exciting recent work that has provided elegant detail for CRISPR/Cas targeting to DNA, using protein-RNA complexes from bacteria and archaea, and aim to unify this with more general interest in R-loops. 8 
Discovery of CRISPR/Cas RNA-Based Immunity in Bacteria and Archaea
The bedrock of CRISPR/Cas systems is repetitive DNA sequence in prokaryotes called CRISPR (Clustered Regularly Interspersed Short Palindromic Repeats). The name CRISPR was first used in 2002, 36 but Escherichia coli CRISPRs were noted earlier as unusual sequence repeats proximal to a gene encoding an alkaline phosphatase isozyme (iap). 37 Similar short repetitive sequences under different names were described in bacteria and archaea, [38] [39] [40] distinguished by significant differences to other classes of widespread short sequence repeats in bacteria, ERICs and REPs. In a landmark Helicase unwinding R-loops 35 paper, 36 comparison of these new sequence repeats in multiple species brought on the name CRISPR, defined by two factors: (a) Sequence repeats of 20-30 nt are interspersed with "spacers" of variable non-repeat sequence of 20-75 nt. (b) CRISPR associated (Cas) proteins that are conserved in many organisms with amino acid motifs characteristic of nucleic acid processing enzymes (Fig. 2) . Significantly, at about the same time, CRISPR RNA (crRNA) transcripts that were much shorter than full-length CRISPR loci were detected, suggesting endonucleolytic processing of crRNA. 43 At that point, the prevailing mood was that CRISPR/Cas, particularly Cas proteins, cooperated in DNA replication, recombination and repair. [44] [45] [46] Observations in bacteria and archaea that the nonrepeat spacers within CRISPR matched sequences from plasmids, phages and prophages, [47] [48] [49] stimulated a new hypothesis: CRISPR provides defence against viruses in archaea 50 through an immune system based on RNAi (RNA interference)-like mechanisms. 51 In 2007, experimental manipulation of CRISPR spacer sequences in Streptococcus thermophilus DGCC7710, an important bacterium for the dairy industry, was shown to protect cells from decimation by phage, dependent on a then unknown activity of a Cas protein (Cas5, now called Cas9/Csn1). 52, 53 The common theme in each system is the presence of a CRISPR locus, although there is variation in the number of repeats and repeat/ spacer sequence composition. However, conservation of underlying principles of CRISPR immunity in different species was shown recently, by introduction of S. thermophilus CRISPR-3 into E. coli conferring heterologous protection against plasmid and phage. 53 CRISPR/Cas systems have undergone two iterations of classification based on Cas protein distribution that is subdivided into three types (I, II and III). 54, 55 This is reflected in major mechanistic differences in how CRISPR sequences are manipulated for immunity and protection. Overall, in all systems, CRISPR/Cas operates through three major processes, each catalysed by distinct nucleic acid processing enzymes ( Fig. 2) : (a) adaptation, incorporation of a DNA fragment from a nonself invasive element (called a "pre-spacer") into a CRISPR locus as a "spacer" alongside a new CRISPR repeat, and (b) transcription and processing of crRNA to arm a protein complex for (c) interference/targeting of nucleic acid sequence, called a "protospacer" if the target is DNA, by homologous sequence in crRNA leading to destruction of the invasive plasmid or phage.
Recent reviews detail these processes and regulation of cas genes and CRISPR. 52, [56] [57] [58] [59] [60] [61] In summary, adaptation is poorly understood, but CRISPR loci can acquire new spacer sequence derived from nonself DNA, alongside a new repeat, in response to exposure to phage. [62] [63] [64] In the E. coli type I CRISPR system, adaptation relies on nucleases Cas1 and Cas2 65, 66 through unknown mechanisms in which protospacer is directed for incorporation as a spacer. 67 Adaptation in the type II CRISPR system (CRISPR-3) of S. thermophilus requires Csn2 protein, also by unknown mechanisms. 41, 42, 68, 69 Transcription of CRISPR from an AT-rich leader sequence generates precursor crRNA (pre-crRNA), which is endonucleolytically shortened into mature crRNA by cleavage in repeat sequences. Two major nuclease groups, Cas6 and Cas9, catalyse crRNA formation, depending on the particular CRISPR/ Cas system: using the nomenclature of reference, 55 these are called Cas6, 70, 71 Cas6e (previously called CasE and Cse3), [72] [73] [74] Cas6f (previously, Csy4) 75 and Cas9-RNase III complex. 76 crRNA is used to target foreign nucleic acid by protein complexes that guide it to complementary nucleotide sequence. In archaeal type III CRISPR systems of Pyrococcus furiosus and Sulfolobus solfataricus, crRNA is held in a complex called CMR [77] [78] [79] (Cas module RAMP, where RAMP was originally used to mean RepeatAssociated Mysterious Proteins 51 ). CMR targets crRNA to other RNA molecules, presumed to be viral mRNA, which are cleaved with mechanistic differences between P. furiosus and S. solfataricus CMR. [77] [78] [79] In the next sections, we focus on CRISPR interference strategies that use crRNA to target duplex DNA in stable DNA-RNA hybrids. Emerging evidence suggests two main routes for this, each requiring different Cas proteins: Cas9 protein typical of type II CRISPR systems or a multi-protein complex called Cascade, synonymous with the interference stage of type I CRISPR systems.
crRNA to Target DNA: Cas9 and Cascade
Cas9
First models of CRISPR/Cas as a prokaryotic immunity system suggested that Cas proteins manipulate crRNA to target invading RNA, similarly to RNAi in eukaryotes. 51 CMR complexes do target RNA, as noted in the previous section. Similarities and distinctions between CRISPR systems and eukaryotic RNAi have been reviewed recently. 61 Other CRISPR/Cas systems use crRNA to target DNA. Before biochemical mechanisms of crRNA-DNA targeting came to light, it was known that spacer sequences transcribed to crRNA in the bacterium S. thermophilus match phage DNA sequence from both coding and template strands, 47 suggesting targeting of either strand of phage DNA. This was also inferred in E. coli, in experiments using an engineered CRISPR/Cas system to protect against phage λvir, 72 and in Staphylococcus epidermidis. In the latter, a nickase gene from a conjugative plasmid could be blocked by a CRISPR system at the level of DNA but not mRNA. 80 Crucially, another study in S. thermophilus showed that doublestranded DNA is targeted rapidly (b 2 min) by CRISPR/Cas, by a mechanism that required Cas5 (now called Cas9), resulting in nuclease degradation of target DNA. 81 An absolute requirement for S. thermophilus Cas9 in CRISPR targeting to plasmid DNA was confirmed later. 53 Cas9 may also have a role in RNaseIII-mediated processing of pre-crRNA to crRNA in some species. 76 Not much is known about the structure or function of Cas9 protein. It is a large protein (N 1200 amino acids) with conserved motifs typical of RuvC/RNaseH nucleases that are needed for Cas9 function in vivo. 53 Perhaps, Cas9 multitasks, contributing to preparation of crRNA that is retained for targeting and destruction of DNA in a way analogous to Cascade complexes, which we now look at in detail.
Cascade: A crRNA interference complex in type I systems
Cascade (CRISPR-Associated Complex for Antiviral Defence) is a multi-protein ribonucleic acid complex that forms R-loops with complementary DNA sequence, catalysing interference stages of CRISPR immunity in bacteria and archaea. The complex was identified in E. coli, in which it remains tightly bound to crRNA that it has formed from precrRNA by endonucleolytic cleavage. 72 In the same study an important proof of principle was reported; co-expression of Cascade with a crRNA construct complementary to viral DNA, as well as an additional protein (Cas3), was sufficient to give robust protection of E. coli cultures against plaque formation by phage λvir. The use of ectopic expression of these individual components from plasmids in an E. coli strain lacking cas genes was prescient, side-stepping BaeSR, H-NS/LeuO-mediated transcriptional regulation of E. coli CRISPR/cas that subsequently came to light. [82] [83] [84] The hypothesis that crRNA is targeted to viral DNA of either strand, involving Cascade and Cas3 proteins that are widely distributed in type I CRISPR systems, was established.
E. coli Cascade comprises five proteins, originally called CasABCDE, 72 now Cse1(CasA), Cse2(CasB), Cas7(CasC), Cas5(CasD) and Cas6e(CasE). All of these are required to protect E. coli cells against lytic phage in plaque assays. 85 A remarkable sequence of work in the last few years has established how E. coli Cascade forms R-loops. These principles probably translate into other Cascade complexes, based on functional studies of a Cas5-Cas7-crRNA complex in S. solfataricus, 86 an archaeal species that also processes crRNA within a CMR complex, 79 and studies of Pseudomonas aeruginosa PA14 Csy1-Csy4 (now called Csy1, Csy2, Csy3 and Cas6f), 87 which has structural similarities to Cascade from E. coli 85 despite there being little sequence similarity between the respective proteins.
E. coli
Cascade has a stoichiometry of 1:2:6:1:1 (Cse1:Cse2:Cas7:Cas5:Cas6e) in a 405-kDa protein complex bound to crRNA. 85 This crRNA comprises a 32-nt spacer core flanked with an 8-nt 5′ handle and a 21-nt 3′ hairpin loop. The overall morphology of Cascade, described as a seahorse, 85 has a prominent backbone of six Cas7 subunits within which a crRNA cord dictates assembly of Cas7 as a nucleoprotein helix. 88 Filamentous Cas7 backbone is also clear when imaged from S. solfataricus. 86 A 5′ end crRNA hook neatly delimits assembly of multiple Cas7 subunits through interaction with the sixth Cas7 subunit. 88 Cse1 is also proximal to the 5′ hook. At the other end of the complex is Cas6e, the Cascade ribonuclease that remains bound to crRNA 3′ end, which is a hairpin loop in E. coli.
A Recipe for R-Loops: Cascade, PAM, Seeds and Supercoils
Cascade establishes an R-loop by base pairing crRNA to protospacer DNA that has sequence and structure betraying it as a bona fide target (Fig. 3) . Cascade and Csy1-Csy4 operate a policy of selective engagement with DNA, triggering R-loop formation when encountering "seed" sequence and, at least in the E. coli system, a protospacer adjacent motif (PAM). The seed sequence is probably a common mechanism in all crRNA-DNA pairing through thermodynamic considerations, offering a minimum length requirement for a stable RNA-DNA hybrid forming at the 5′ end of crRNA that displaces an unpaired DNA strand in an R-loop. Similar seeding is responsible for RNA-RNA pairing by Argonautes in eukaryotic RNAi 61 and is important for both Cascade and Csy1-Csy4 complexes. 87, 89 Similarities have been noted in structure and function of nucleoprotein filaments formed by archaeal Cas7-crRNA and the bacterial recombinase RecA in complex with ssDNA. 86 RecA filaments catalyse pairing with homologous duplex DNA forming Dloops from seed sequences, and it may be the case that similar forces apply in R-loop formation by Cascades.
In contrast to seeding of R-loop formation, in ways probably common in other biological processes, PAMs can give CRISPR interference sequence specificity. PAMs are typically of 2-3 nt, upstream of protospacer DNA, and they do not match crRNA sequence. Originally, PAMs were recognised as a pattern of nucleotide motifs juxtaposed to protospacer/pre-spacer sequence of invasive DNA in S. thermophilus and other CRISPR loci. 47, 63, 90, 91 In E. coli, where a trinucleotide PAM is located at positions − 3 to − 1 relative to crRNAprotospacer base pairing, substitutions to PAM in M13 phage allowed escape from E. coli Cascade targeting, measured as efficiency of plaque formation on E. coli cell lawns. 89 The presence, absence or manipulation of PAM sequence in plasmid targets resulted in altered efficiency of binding by purified E. coli Cascade. 92 Dissociation constants (K d ) were at least 19 times higher for Cascade binding a negatively supercoiled plasmid lacking PAM compared to the same plasmid with a PAM and 3 times higher when PAM sequence was altered to an escape sequence that had been identified in E. coli by plaque assays. 89 It had been noted previously that DNA binding by E. coli Cascade relied on its Cse1 subunit 85 and that target binding by Cascade can result in movement of Cse1 (as well as Cse2 and Cse6e) relative to the Cas7 backbone. 88 Mechanistic detail of Cse1 function is now available from biochemistry of E. coli Cascade and the crystal structure of Cse1 from T. thermophilus. 93 The key to Cse1 in this instance is a trio of amino acids that includes a phenylalanine forming a loop (L1) that is needed for effective protection by Cascade in vivo and is positioned such that it might recognise PAM and destabilise target duplex. Interestingly, Sulfolobus Cascade lacks a clear sequence homologue of Cse1 yet PAM sequences are important for targeting reactions in this organism. 86, 94 P. aeruginosa Csy1-Csy4 lacks Cse1 and shows only sequence-specific DNA binding, requiring the seed DNA sequence. These recent insights into Cascade molecular biology indicate how this nucleoprotein complex sets up an R-loop by distinguishing nonself DNA from self and scanning for seeding sites.
Recent work revealed an elegant solution to how E. coli Cascade gains energy for scanning, seeding and conformational movements: negatively supercoiled DNA. 92 The chromosome of E. coli is maintained in a negatively supercoiled state. It is well known that hypernegative supercoiling promotes R-loop formation globally in bacteria, which causes cell inviability if supercoils are not relaxed by topoisomerase I. 8 Cascade provides the means to exploit this in a targeted way, once it has established that DNA is nonself by mechanisms described above. All that is then left to do is destroy target DNA. This is less well understood, but recent work has confirmed that interaction of Cascade with Cas3 protein facilitates this.
How to Destroy an R-Loop: Cas3 Nuclease-Helicase
Interplay between Cas3 and Cascade in protection against phage λvir was identified in E. coli.
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Subsequent biochemical studies were above all in other species because of instability of E. coli Cas3 for purification unless fused to maltose binding protein 35 or more recently to Cse1. 92 The latter work confirmed that E. coli Cas3 is a nuclease active against ssDNA, with both exonuclease and endonuclease activities residing in an HD domain, in agreement with nuclease activities of other Cas3 proteins. [95] [96] [97] [98] In addition to HD nuclease activity, Cas3 has superfamily 2 helicase motifs that power ATP-dependent translocation 3′ to 5′ along ssDNA, 98 through R-loops. 35 Cas3 translocation stimulates exonuclease activity, 92, 95 consistent with a multitasking machine that can processively degrade the invasive target DNA (Fig. 3) . Fusion of E. coli Cas3 with Cse1 for in vitro studies efficiently targeted Cas3 nuclease to plasmid DNA with PAM and seed sequences and mimics strong evidence for physical interaction of Cse1 with Cas3 in E. coli.
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Summary Remarks: CRISPR Targeting Linked to Spacer Acquisition? E. coli Cascade, archaeal Cascade and Csy1-Csy4 complexes all catalyse a core process, DNA-targeted R-loop formation. This can be adorned by mechanistic specificity arising from accessory proteins, Cse1 and unknown partners in archaea. This is parallel in DNA helicase-translocase superfamilies that manipulate diverse nucleic acid structures using specificity inducing accessory domains surrounding a RecA core of ATPase domains. A mechanistic framework for CRISPR/Cas, at least in E. coli, is now apparent: Transcriptional activation of CRISPR and Cascade [82] [83] [84] 99 sets in motion targeting of Cascade ribonucleoprotein complex to invasive DNA, forming a stable R-loop (Fig. 3) . Cas3 is recruited via Cse1, which places it close to the 3′ tail of target DNA upstream of the crRNA-DNA seed sequence. Cas3 nicks DNA to relax supercoiling for robust degradation of the remaining DNA strand using 3′-to-5′ ATP-dependent translocase-nuclease activities.
Cas3 nuclease activities can be mapped onto crystal structures of Cas3 HD domains (called Cas3″), 95, 97 but there is currently no crystal structure of Cas3 superfamily 2 helicase domains. When this information becomes available, it might cast some light on some interesting conserved features at the C-terminus of Cas3 sequences that are not canonical helicase motifs and with no known function at present. To understand how Cas3 is orientated onto target DNA, it will be necessary to understand how it interacts with Cse1: precise loading of Cas3 for translocation 3′ to 5′ along target ssDNA would be an effective means of displacing Cascade-crRNA complex undamaged for recycling to subsequent targets. It is likely that crRNA in R-loops is protected from RNaseH, a potent nuclease against RNA in RNA-DNA hybrids, by its extensive shielding by the Cascade/Csy1-Csy4 backbone. A recent report that E. coli Cas3 is a client protein for the Hsp90 protein HtpG 100 offers an intriguing possibility that Cas3, which is not co-transcribed with Cascade, is tethered until recruited by Cse1/Cascade. This might be a way to prevent indiscriminate DNasehelicase activity or interaction with other cellular proteins, but there is no information on handover of Cas3 from HtpG to Cse1. Does R-loop formation by Cascade and/or nuclease processing by Cas3 promote acquisition of protospacer DNA into CRISPR loci as spacers? It is tempting to speculate that Cascade R-loops might trigger recombination or integration of invasive DNA into CRISPR loci akin to R-loop-directed CSR into repetitive switch (S) regions in mammalian immune systems. 15 S-regions, like CRISPR loci, contain short repeats (25-80 bp) and sequence motifs that direct recombination events downstream of a promoter. At the time of writing, a feedback loop between CRISPR interference and adaptation has been suggested. 67 Given how little is known about adaptation, presumably involving at least Cas1 and Cas2 proteins, this should prove another interesting mechanism to work out.
